0001209191-17-045272.txt : 20170714 0001209191-17-045272.hdr.sgml : 20170714 20170714200639 ACCESSION NUMBER: 0001209191-17-045272 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170714 FILED AS OF DATE: 20170714 DATE AS OF CHANGE: 20170714 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SANGAMO THERAPEUTICS, INC CENTRAL INDEX KEY: 0001001233 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 680359556 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 501 CANAL BLVD STREET 2: POINT RICHMOND TECH CNTR. CITY: RICHMOND STATE: CA ZIP: 94804 BUSINESS PHONE: 5109706000 MAIL ADDRESS: STREET 1: 501 CANAL BLVD STREET 2: POINT RICHMOND TECH CNTR. CITY: RICHMOND STATE: CA ZIP: 94804 FORMER COMPANY: FORMER CONFORMED NAME: SANGAMO BIOSCIENCES INC DATE OF NAME CHANGE: 20000208 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Herberts Curt A. III CENTRAL INDEX KEY: 0001691262 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30171 FILM NUMBER: 17966396 MAIL ADDRESS: STREET 1: 501 CANAL BLVD. STREET 2: POINT RICHMOND TECH CENTER CITY: RICHMOND STATE: CA ZIP: 94804 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-07-14 0 0001001233 SANGAMO THERAPEUTICS, INC SGMO 0001691262 Herberts Curt A. III C/O SANGAMO THERAPEUTICS, INC. POINT RICHMOND TECH CTR, 501 CANAL BLVD. RICHMOND CA 94804 0 1 0 0 Sr.VP & Chief Business Officer Common Stock 2017-07-14 4 M 0 172 3.99 A 35517 D Common Stock 2017-07-14 4 S 0 172 10.00 D 35345 D Common Stock 2017-07-14 4 S 0 14828 10.00 D 20517 D Stock Option (Right to Buy) 3.99 2017-07-14 4 M 0 172 0.00 D 2020-10-17 Common Stock 172 3474 D All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2017. The shares underlying the stock option are fully vested and exercisable. /s/ Florence Tam, Attorney-in-Fact 2017-07-14